Logo image of BRN

BARNWELL INDUSTRIES INC (BRN) Stock Fundamental Analysis

NYSEARCA:BRN - NYSE Arca - US0682211000 - Common Stock - Currency: USD

1.2237  +0.01 (+1.13%)

Fundamental Rating

2

Taking everything into account, BRN scores 2 out of 10 in our fundamental rating. BRN was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. BRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BRN had negative earnings in the past year.
In the past year BRN had a positive cash flow from operations.
In multiple years BRN reported negative net income over the last 5 years.
In the past 5 years BRN always reported a positive cash flow from operatings.
BRN Yearly Net Income VS EBIT VS OCF VS FCFBRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

BRN's Return On Assets of -25.65% is on the low side compared to the rest of the industry. BRN is outperformed by 92.49% of its industry peers.
BRN's Return On Equity of -61.70% is on the low side compared to the rest of the industry. BRN is outperformed by 88.26% of its industry peers.
Industry RankSector Rank
ROA -25.65%
ROE -61.7%
ROIC N/A
ROA(3y)-2.01%
ROA(5y)-2.36%
ROE(3y)-6.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRN Yearly ROA, ROE, ROICBRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

The Gross Margin of BRN (33.54%) is comparable to the rest of the industry.
BRN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.64%
GM growth 5Y15.73%
BRN Yearly Profit, Operating, Gross MarginsBRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRN has more shares outstanding
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRN Yearly Shares OutstandingBRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
BRN Yearly Total Debt VS Total AssetsBRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

BRN has an Altman-Z score of 0.53. This is a bad value and indicates that BRN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BRN (0.53) is worse than 65.26% of its industry peers.
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.53
ROIC/WACCN/A
WACC8.93%
BRN Yearly LT Debt VS Equity VS FCFBRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.99 indicates that BRN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.99, BRN is in line with its industry, outperforming 41.31% of the companies in the same industry.
A Quick Ratio of 0.99 indicates that BRN may have some problems paying its short term obligations.
BRN's Quick ratio of 0.99 is in line compared to the rest of the industry. BRN outperforms 52.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
BRN Yearly Current Assets VS Current LiabilitesBRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

BRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.78%.
The Revenue for BRN has decreased by -25.45% in the past year. This is quite bad
Measured over the past years, BRN shows a quite strong growth in Revenue. The Revenue has been growing by 11.94% on average per year.
EPS 1Y (TTM)-91.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.17%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y9.03%
Revenue growth 5Y11.94%
Sales Q2Q%-32.33%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRN Yearly Revenue VS EstimatesBRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRN Price Earnings VS Forward Price EarningsBRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRN Per share dataBRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

BRN has a Yearly Dividend Yield of 2.31%. Purely for dividend investing, there may be better candidates out there.
The stock price of BRN dropped by -25.31% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
BRN's Dividend Yield is comparable with the industry average which is at 6.42.
Compared to an average S&P500 Dividend Yield of 2.43, BRN has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

BRN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BRN Yearly Dividends per shareBRN Yearly Dividends per shareYearly Dividends per share 2022 2023 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BRN Yearly Income VS Free CF VS DividendBRN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

More info and screens

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (6/27/2025, 10:09:12 AM)

1.2237

+0.01 (+1.13%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-11 2025-08-11
Inst Owners12.35%
Inst Owner Change-2.63%
Ins Owners54.77%
Ins Owner Change1.87%
Market Cap12.30M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF 8.2
P/B 1.21
P/tB 1.21
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.15
OCFY12.19%
SpS1.78
BVpS1.01
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.65%
ROE -61.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.54%
FCFM N/A
ROA(3y)-2.01%
ROA(5y)-2.36%
ROE(3y)-6.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.64%
GM growth 5Y15.73%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.66%
Cap/Sales 25.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.53
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)232.65%
Cap/Depr(5y)208.92%
Cap/Sales(3y)33.56%
Cap/Sales(5y)25.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y9.03%
Revenue growth 5Y11.94%
Sales Q2Q%-32.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.3%
OCF growth 3Y78.3%
OCF growth 5YN/A